These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26776348)

  • 1. Currently known risk factors for hypertrophic skin scarring: A review.
    Butzelaar L; Ulrich MM; Mink van der Molen AB; Niessen FB; Beelen RH
    J Plast Reconstr Aesthet Surg; 2016 Feb; 69(2):163-9. PubMed ID: 26776348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring.
    Mehta M; Branford OA; Rolfe KJ
    Burns Trauma; 2016; 4():15. PubMed ID: 27574685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Scar Prevention and Management: Overview of current therapies.
    Al-Shaqsi S; Al-Bulushi T
    Sultan Qaboos Univ Med J; 2016 Feb; 16(1):e3-8. PubMed ID: 26909210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars.
    Bai XZ; Liu JQ; Yang LL; Fan L; He T; Su LL; Shi JH; Tang CW; Zheng Z; Hu DH
    Br J Pharmacol; 2016 May; 173(10):1589-601. PubMed ID: 26891034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scar massage for hypertrophic burns scarring-A systematic review.
    Ault P; Plaza A; Paratz J
    Burns; 2018 Feb; 44(1):24-38. PubMed ID: 28669442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.
    Berman B; Maderal A; Raphael B
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S3-S18. PubMed ID: 27347634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Updated Review of Hypertrophic Scarring.
    Mony MP; Harmon KA; Hess R; Dorafshar AH; Shafikhani SH
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review Comparing Animal and Human Scarring Models.
    Mistry R; Veres M; Issa F
    Front Surg; 2022; 9():711094. PubMed ID: 35529910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound Healing: A Cellular Perspective.
    Rodrigues M; Kosaric N; Bonham CA; Gurtner GC
    Physiol Rev; 2019 Jan; 99(1):665-706. PubMed ID: 30475656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro.
    Chong CH; Sun JM; Liu YX; Tsai YT; Zheng DN; Zhang YF; Yu L
    Aesthetic Plast Surg; 2023 Aug; 47(4):1587-1597. PubMed ID: 36810832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring.
    Yin J; Zhang S; Yang C; Wang Y; Shi B; Zheng Q; Zeng N; Huang H
    Front Immunol; 2022; 13():1028410. PubMed ID: 36325354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese medicine for hypertrophic scars-A review of the therapeutic methods and potential effects.
    Chen D; Li Q; Zhang H; Kou F; Li Q; Lyu C; Wei H
    Front Pharmacol; 2022; 13():1025602. PubMed ID: 36299876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-Regulating Scar Formation by Microneedles Directly
    Zhang Q; Shi L; He H; Liu X; Huang Y; Xu D; Yao M; Zhang N; Guo Y; Lu Y; Li H; Zhou J; Tan J; Xing M; Luo G
    ACS Nano; 2022 Jul; 16(7):10163-10178. PubMed ID: 35617518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models.
    Griffin MF; Borrelli MR; Garcia JT; Januszyk M; King M; Lerbs T; Cui L; Moore AL; Shen AH; Mascharak S; Diaz Deleon NM; Adem S; Taylor WL; desJardins-Park HE; Gastou M; Patel RA; Duoto BA; Sokol J; Wei Y; Foster D; Chen K; Wan DC; Gurtner GC; Lorenz HP; Chang HY; Wernig G; Longaker MT
    Sci Transl Med; 2021 Sep; 13(609):eabb3312. PubMed ID: 34516825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of Inflammation in Keloid and Hypertrophic Scars.
    Wang ZC; Zhao WY; Cao Y; Liu YQ; Sun Q; Shi P; Cai JQ; Shen XZ; Tan WQ
    Front Immunol; 2020; 11():603187. PubMed ID: 33343575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.
    Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ
    Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts.
    Park GS; An MK; Yoon JH; Park SS; Koh SH; Mauro TM; Cho EB; Park EJ; Kim KH; Kim KJ
    Arch Dermatol Res; 2019 Dec; 311(10):807-814. PubMed ID: 31501922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin Acute Wound Healing: A Comprehensive Review.
    Cañedo-Dorantes L; Cañedo-Ayala M
    Int J Inflam; 2019; 2019():3706315. PubMed ID: 31275545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.